Valeant nears deal to buy Salix for about $10 billion -WSJ

Sat Feb 21, 2015 4:22pm EST
 
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

Feb 21 (Reuters) - Valeant Pharmaceuticals International is near a deal to buy Salix Pharmaceuticals Ltd for about $10 billion, the Wall Street Journal reported on Saturday. (Reporting by Eric Beech)